Loading stock data...
Last Updated: 10 Mar 2026, 03:22:45 PM (IST)

BDH Industries Limited

BSE: BDH

BSE
369.65 -4.35 (-1.16%)

Prev Close

374

Open Price

374

Volume

893

Today Low / High

361.6 / 374

52 WK Low / High

241 / 523.75

Range

351 - 388

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 369.65, reflecting a change of -4.35 (-1.1631%). The expected target range on the BSE is 351 - 388. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

BDH Industries Limited Graph

BDH Industries Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for BDH Industries Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 369.65, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 369.65 373.35 336.01 - 410.68
377.04 301.63 - 452.45
380.74 266.52 - 494.96
Bearish Scenario 369.65 365.95 329.36 - 402.55
362.26 289.81 - 434.71
358.56 250.99 - 466.13

Overview of BDH Industries Limited

ISIN

INE278D01018

Industry

Medical - Pharmaceuticals

Vol.Avg

3,726

Market Cap

2,241,316,890

Last Dividend

4.5

Official Website

Visit Website

IPO Date

2002-04-12

DCF Diff

-1.09

DCF

390

Financial Ratios Every Investor Needs

Stock Dividend of BDH

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-08-01 August 01, 25 4.5 4.5 2025-08-01 2025-09-06
2024-08-02 August 02, 24 4.5 4.5 2024-08-02 2024-09-07
2023-08-02 August 02, 23 4 4 2023-08-02 2023-09-08
2022-08-12 August 12, 22 3.6 3.6 2022-08-17 2022-09-23
2021-08-17 August 17, 21 3 3 2021-08-18 2021-09-24

Stock Rating Details for BDH

Metric Value Recommendation
Overall Rating C Sell
DCF Score 4 Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 65.94 Cr 41.40 Cr 23.49 Cr 0.3562 0.23 Cr 0.91 Cr 10.35 Cr 9.27 Cr 16.11 13.45 Cr 0.1406
2024-03-31 84.84 Cr 60.28 Cr 24.56 Cr 0.2895 0.60 Cr 0.63 Cr 11.16 Cr 9.87 Cr 17.14 14.01 Cr 0.1163
2023-03-31 73.84 Cr 49.68 Cr 24.15 Cr 0.3271 0.60 Cr 0.64 Cr 10.38 Cr 8.20 Cr 14.25 11.79 Cr 0.1111
2022-03-31 68.55 Cr 48.98 Cr 19.57 Cr 0.2855 0.55 Cr 0.45 Cr 8.45 Cr 7.22 Cr 12.55 10.41 Cr 0.1054
2021-03-31 56.33 Cr 37.18 Cr 19.15 Cr 0.3399 0.24 Cr 0.41 Cr 7.73 Cr 6.36 Cr 11.05 9.82 Cr 0.1129

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 31.16 Cr 86.94 Cr 18.18 Cr 68.7617 Cr 0.98 Cr -30.18 Cr 7.39 Cr 19.66 Cr 0.00 Cr 0.00 Cr 0.35 Cr 16.9168 Cr
2024-03-31 25.14 Cr 93.41 Cr 31.25 Cr 62.1578 Cr 8.69 Cr -16.45 Cr 5.00 Cr 20.35 Cr 0.00 Cr 0.00 Cr 0.35 Cr 30.6553 Cr
2023-03-31 25.38 Cr 80.03 Cr 25.33 Cr 54.6945 Cr 4.85 Cr -20.54 Cr 7.16 Cr 19.03 Cr 0.00 Cr 0.00 Cr 0.35 Cr 24.6108 Cr
2022-03-31 18.17 Cr 68.91 Cr 20.33 Cr 48.5872 Cr 2.25 Cr -15.92 Cr 6.71 Cr 19.61 Cr 0.00 Cr 0.00 Cr 0.00 Cr 19.5852 Cr
2021-03-31 21.95 Cr 70.90 Cr 27.83 Cr 43.0689 Cr 8.51 Cr -13.44 Cr 5.43 Cr 20.31 Cr 0.00 Cr 0.00 Cr 0.00 Cr 26.9470 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 14.7709 Cr 1.6241 Cr -10.3748 Cr 14.5562 Cr 6.0202 Cr 31.1579 Cr -0.2147 Cr 9.2733 Cr -7.7110 Cr -2.5908 Cr -2.3843 Cr
2024-03-31 -1.8698 Cr -0.3127 Cr 1.3590 Cr -3.7632 Cr -0.8235 Cr 25.1377 Cr -1.8934 Cr 9.8678 Cr 3.8432 Cr -2.3029 Cr 2.1599 Cr
2023-03-31 6.2939 Cr 0.4868 Cr 0.3653 Cr 6.2897 Cr 7.1460 Cr 25.9612 Cr -0.0042 Cr 11.0677 Cr 2.5958 Cr -2.0726 Cr -0.4499 Cr
2022-03-31 3.0164 Cr 1.3837 Cr -8.2079 Cr 2.7982 Cr -3.8078 Cr 18.8152 Cr -0.2182 Cr 9.5538 Cr -6.2554 Cr -1.7272 Cr -1.2852 Cr
2021-03-31 0.7842 Cr 1.2878 Cr -2.4378 Cr 0.7696 Cr -0.3658 Cr 22.6230 Cr -0.0146 Cr 8.7454 Cr -0.7165 Cr -1.4393 Cr -0.4146 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 29.34 Cr 24.23 Cr 5.10 Cr 0.1740 4.01 Cr 3.49 Cr 6.06 4.23 Cr 0.1189
2025-09-30 18.96 Cr 12.74 Cr 6.22 Cr 0.3282 3.11 Cr 2.62 Cr 4.55 3.88 Cr 0.1381
2025-06-30 18.62 Cr 13.75 Cr 4.88 Cr 0.2619 1.90 Cr 1.83 Cr 3.17 2.66 Cr 0.0981
2025-03-31 17.82 Cr 11.55 Cr 6.84 Cr 0.3839 2.83 Cr 2.49 Cr 4.33 3.63 Cr 0.1396
2024-12-31 16.20 Cr 8.98 Cr 7.22 Cr 0.4458 3.30 Cr 2.81 Cr 4.88 3.99 Cr 0.1734

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 36.13 Cr 0.00 Cr 36.13 Cr 16.26 Cr 5.11 Cr 69.20 Cr 19.23 Cr 88.93 Cr 18.31 Cr
2025-06-30 0.00 Cr 0.00 Cr 31.16 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -68.76 Cr
2025-03-31 31.16 Cr 0.00 Cr 31.16 Cr 14.18 Cr 7.39 Cr 66.75 Cr 19.66 Cr 86.94 Cr 18.18 Cr
2024-12-31 0.00 Cr 0.00 Cr 27.12 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -63.54 Cr
2024-09-30 27.12 Cr 0.00 Cr 27.12 Cr 20.15 Cr 5.52 Cr 67.69 Cr 19.94 Cr 88.08 Cr 24.54 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 1.83 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 2.49 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 2.81 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 2.41 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 1.57 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹830.35 ₹99,644,807,413.00 ₹76,499.00

Key Executives

Executive Director
Ankit Suresh Kachhara

Gender: male

Year Born:

Joint MD, Chief Financial Officer & Executive Director
Suresh Chandra Kachhara

Gender: male

Year Born: 1954

Chairperson & MD
Jayashree G. Nair

Gender: female

Year Born: 1942

Compliance Officer & Company Secretary
Nikita Shashikant Phatak

Gender: female

Year Born:

FAQs about BDH Industries Limited

Who is the CEO of the company?

The CEO is Jayashree G. Nair.

What is the current market price of the stock?

The current price is ₹389.30.

What is the 52-week price range?

The range is ₹241-523.75.

What is the market capitalization of the company?

The market capitalization is ₹224.13 crores.

What is the dividend yield?

The dividend yield is 1.16%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 21.50.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of BDH Industries Limited (ISIN: INE278D01018) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹224.13 crores and an average daily volume of 3,726 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹4.5.